MACLEODS PHARMS LTD FDA Approval ANDA 214751

ANDA 214751

MACLEODS PHARMS LTD

FDA Drug Application

Application #214751

Application Sponsors

ANDA 214751MACLEODS PHARMS LTD

Marketing Status

Prescription001

Application Products

001OINTMENT;TOPICAL100,000 UNITS/GM;0.1%0NYSTATIN AND TRIAMCINOLONE ACETONIDENYSTATIN; TRIAMCINOLONE ACETONIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-08-17STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAT

CDER Filings

MACLEODS PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214751
            [companyName] => MACLEODS PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"NYSTATIN AND TRIAMCINOLONE ACETONIDE","activeIngredients":"NYSTATIN; TRIAMCINOLONE ACETONIDE","strength":"100,000 UNITS\/GM;0.1%","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/17\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-08-17
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.